Cargando…
A Midgut Digestive Phospholipase A(2) in Larval Mosquitoes, Aedes albopictus and Culex quinquefasciatus
Phospholipase A(2) (PLA(2)) is a secretory digestive enzyme that hydrolyzes ester bond at sn-2 position of dietary phospholipids, creating free fatty acid and lysophospholipid. The free fatty acids (arachidonic acid) are absorbed into midgut cells. Aedes albopictus and Culex quinquefasciatus digesti...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976925/ https://www.ncbi.nlm.nih.gov/pubmed/29862070 http://dx.doi.org/10.1155/2018/9703413 |
Sumario: | Phospholipase A(2) (PLA(2)) is a secretory digestive enzyme that hydrolyzes ester bond at sn-2 position of dietary phospholipids, creating free fatty acid and lysophospholipid. The free fatty acids (arachidonic acid) are absorbed into midgut cells. Aedes albopictus and Culex quinquefasciatus digestive PLA(2) was characterized using a microplate PLA(2) assay. The enzyme showed substantial activities at 6 and 8 μg/μl of protein concentration with optimal activity at 20 and 25 μg/μl of substrate concentration in Aedes albopictus and Culex quinquefasciatus, respectively. PLA(2) activity from both mosquitoes increased in a linear function up to 1 hour of the reaction time. Both enzymes were sensitive to pH and temperature. PLA(2) showed higher enzyme activities in pH 8.0 and pH 9.0 from Aedes albopictus and Culex quinquefasciatus, respectively, at 40°C of incubation. The PLA(2) activity decreased in the presence of 5 mM (Aedes albopictus) and 0.5 mM (Culex quinquefasciatus) site specific PLA(2 )inhibitor, oleyloxyethylphosphorylcholine. Based on the migration pattern of the partially purified PLA(2) on SDS-PAGE, the protein mass of PLA(2) is approximately 20–25 kDa for both mosquitoes. The information on PLA(2) properties derived from this study may facilitate in devising mosquitoes control strategies especially in the development of inhibitors targeting the enzyme active site. |
---|